Newsletter XXVIII May 2002
2002-2003 Slate Finalized, Voting Underway
President’s Message: The Malpractice Liability Coverage Saga Continues
Applicants To Go Before Credentialing Committee
California's MICRA vs. Current Nevada Law
Clark County Health District Disease Statistics
By Deborah Barton,
CCMS Public Relations Coordinator
You may have already received your Official Voting Ballot
for the 2002-2003 Board of Trustees and Nominating Committee. These candidates
were either placed on the ballot by the Nominating Committee or by write-in on
the Nominating Slate,
mailed to all members in March.
This year, the ballot includes the largest slate of
candidates for the Board of Trustees in recent history. Following are the
candidates (continued on page 2).
President Elect
(One To Be Elected)
Edwin Kingsley, MD, Oncology, 3730 S. Eastern Ave.,
Secretary (One To Be Elected)
Kevin Hyer, MD, Diagnostic
Radiology, 2020 Palomino Ln. #100, Las Vegas, NV
89106
Delegate Chair
(One To Be Elected)
Trustees (Six of
Nine To Be Elected)
Michael Colletti, MD, Rheumatology,
Michael Gross, MD, Nephrology, 1750 E. Desert Inn Rd. #200, Las
Vegas, NV 89109
Jerry Jones, MD, Ob-Gyn,
Alexander Sparkuhl, MD, Urology,
Eugene Speck, MD, Infectious Disease,
David Steinberg, MD, Radiology,
Annette Teijeiro, MD, Anesthesiology,
Nominating
Committee (Seven To Be Elected)
Richard Diskin, DO, Dermatology,
Raj Chanderraj, MD, Cardiology,
Howard Hoffman, Jr., MD, Pathology,
Raul Meoz, MD, Radiation Oncology,
624 S. Tonopah,
Frank Nemec, MD, Gastroenterology, 3131 La
Ronald Slaughter, MD, Pathology,
By R. Glen Woods,
Woods Erickson Whitaker & Miles LLP
Professionals, investors and business owners are rightfully
concerned about the costs of litigation in today’s society. Asset protection has become an accepted part
of any estate plan. Estate planning has
always been about minimizing risks. The
risk of losing one’s assets in litigation has now been added to the traditional
risks of death, disability and income and estate taxes. Any well designed estate plan must deal with
each of these risks, and will include the following:
Effective asset protection planning compliments existing
liability insurance, and is most effective when undertaken before problems
arise. Effective asset protection
planning does not involve excessive complexity, and provides alternatives when
problems arise. Often, asset protection
planning makes use of more than one strategy.
Reliance on insurance has been a solution for many in the past. All of us are aware that things have
changed. Professionals and business
owners who previously depended on liability insurance are keenly aware that
insurance is not the only answer. The
cost of insurance continues to rise, and insurance coverage is not available
for every kind of risk. Even where
insurance is available, the insured cannot count on insurance always being
available. Furthermore, insurance
policies always contain limitations on coverage and exclusions from
coverage. Punitive damages are often not
insured at all. Another common exclusion
is intentional acts. All insurance
policies limit the insurer’s liability, so there is a real possibility that
there may not be enough insurance to pay a covered claim.
Gifts of property
to others, or holding one’s property in another person’s name, have often been
used as a substitute for asset protection planning. All of us know people whose residences,
businesses and investments are held in the names of parents, children or other
family members. However, this does not
really provide any asset protection at all.
There is no protection if the family member becomes involved in
litigation, goes through a divorce, encounters tax difficulties, or dies or
becomes disabled. When this occurs, the
owner is faced with potential loss of the property that the owner was trying to
protect.
Exemptions can
and should be a part of any estate plan.
Most of us are familiar with the homestead exemption, which in
Limited partnerships
are an effective and valuable way to protect one’s assets. Limited partnerships have been used for years
for a variety of purposes, such as reducing estate taxes, minimizing income
taxes, and retaining control of one’s property.
Limited partnerships are frequently an important component of an
effective estate plan and asset protection plan. Investors, professionals and business owners
should give careful consideration to using limited partnerships as a means to hold
investment assets, without loss of control.
However, limited partnerships are not suitable to hold all assets. Other strategies must be used for assets such
as stock in S corporations, since partnerships cannot be stockholders of S
corporations.
Limited partnerships can be drafted to meet a variety of
needs and circumstances. The investor,
professional or business owner, and the owner’s spouse, are frequently named
the general partners, and are given the exclusive right to manage the assets of
the partnership. A limited partnership
that is drafted for asset protection purposes will contain a number of
provisions. Such a partnership agreement
will give to the general partners wide latitude and
discretion in determining whether and when to make distributions to partners of
partnership income or assets. Such a
partnership will also provide that the general partners will remain in office
for as long as they so choose, and will limit or foreclose entirely the ability
of anyone other than the general partners to dissolve or liquidate the partnership. A limited partnership that is drafted for
investment purposes will confer upon the general partners
wide latitude to determine the investments that are appropriate for partnership
assets.
Limited partnerships are effective for asset protection
because, under
Offshore asset
protection trusts have been used for many years. The process of establishing an offshore asset
protection trust is not much different than the process of establishing a trust
in
The offshore asset protection trust presents a more
formidable barrier to a potential litigation plaintiff, particularly in the
case of assets that are located outside
Consider Combining
Strategies
An effective estate plan will often include more than one
asset protection strategy. For example,
an investor, professional or business owner can take advantage of available
homestead laws, the
The limited partner of the limited partnership can be an
asset protection trust, established either under
Once the arrangement is created, if legal difficulties
arise, the professional has the benefit of the limited partnership. If for some reason the limited partnership is
not providing the necessary degree of protection (for example, where a court in
another state is not applying
An asset protection trust, if created in
Conclusion
The principal purpose of an effective asset protection plan
should be to deter litigation, and to encourage a potential plaintiff to accept
whatever the liability insurer is willing to pay to resolve a claim, thereby
avoiding for the professional, business owner or investor the expense and
distraction that can come from litigation.
An effective asset protection strategy will therefore often include more
than one of the elements discussed above.
Any asset protection strategy should therefore be simple, and avoid
unnecessary complexity. In the opinion
of the author, the professional, investor or business owner should never
deprive herself of the control of her own assets. Strategies such as those outlined in this
article should compliment other estate planning techniques, acting as a deterrent
to anyone who might threaten to embroil the professional, investor or business
owner in costly litigation. Of course,
all strategies may or may not be appropriate in any individual case, depending
upon the circumstances. The author
encourages anyone who might be considering asset protection as part of an
estate plan to seek appropriate legal advice, based upon individual needs and
circumstances.
Woods Erickson Whitaker & Miles LLP
(702) 433-9696
By Raj Chanderraj,
M.D., 2001-2002 CCMS President
There are several rumors floating around that the Governor’s
plan is expensive and doesn’t really address our issues. People are being told
that you need to pay a fee to apply and that, if the losses are excessive, the
physicians would be liable.
Folks, we need to calm down, turn down the rhetoric and
examine facts! There is a fee of $5,000 to apply. However, this is credited
towards your premium if you are accepted. I am given to understand that would
be refunded if you do not qualify. The company that is going to insure the
physicians is a private corporation which, like any other company, will try to
recover losses through premium rate increases but not by asking individual
providers to chip in to cover their losses. Each individual physician will be given
a quote depending on their claims history and some may be turned down for
coverage. You will never know until you apply. (See page 5 for preliminary rate
information and page 6 for classification codes, both released by CPON.)
At least for now, for the majority of us there seems to be some affordable coverage. However, in the long run we need to effect a civil justice reform. This will require more committed action from all of us - to influence public opinion and the opinion of legislators. Please don’t sit in the doctors’ lounge and be critical of your colleagues and blame one person or other - get up and contribute words of encouragement; in cooperative and constructive actions and by contributing to the task force. Stand up and be counted. Don’t be a freeloader!
Proposed Annual Base Rates*
$1,000,000/ $3,000,000 Claims Made Policy Limits
*Actual rates charged may vary due to the application of
various rating factors including but not limited to schedule and experience
rating modifications. It is likely that some rates may be up to 10% lower or up
to 50% higher than these base rates depending on the specific circumstances of
the risk. The rates and supplementary rating rules are subject to change and
have not yet been approved by the Commissioner of Insurance. It is expected
that final rates will be available after the Board of Directors meeting on
**No prior acts coverage will be offered so all physicians
will initially be rated at 1.0 year.
RATING CLASSES

RATING CLASSES CLASSIFICATION
CODES
1 80249, 80251,
80492
1A 80254, 80266,
80292
2 80230, 80234, 80236, 80240, 80244, 80247, 80256, 80258, 80283, 80265, 80268,
80270, 80277, 80282, 80285, 80269, 80291, 80294, 80424, 80469, 80475, 80482,
80483
2A 80240, 80423, 80443, 80484, 80487
3 80235, 80241,
80253, 80261, 80262, 80274, 80280, 80288, 80488
3A 80472
3B 80237, 80236, 80243, 80245, 80240, 80248, 80262, 80252, 80257, 80259, 80260,
80269,
80271, 80272, 80270, 80278, 80279, 80284, 80286, 80287, 80473, 80489
3C 80144, 80267,
80293
4 80101, 80103,
80105, 80107, 80108, 80268, 80281, 80470, 80502, 80503
4A 80106, 80151,
80158, 80160
4B 80263, 80491
4C 80471
5 80102, 80145,
80156
6 80186
7 80115, 80117,
80143, 80144, 80146, 80157, 80166, 80169, 80171, 80474
8 80154, 80170,
80501
9 80141, 80150, 80152, 80153, 80167, 80168, 80481
NEIA CLASSIFICATION and CODE NUMBERS
CLASSIFICATION: NO-SURGERY (NS), SURG-ASSIST (SA), ALL-SURGERY (AS)
Aerospace Medicine: 80230 (NS)
Allergy: 80254 (NS)
Anesthesiology: 80151 (AS)
Bronch-Esophagology: 80101 (AS)
Cardiovascular Diseases: 80255(NS), 80281(SA), 80150(AS)
Cardiovascular-Major Invasive Procedures: 80503(NS), 80503(SA)
Dermatology: 80256(NS), 80282(SA), 80472(AS)
Diabetes: 80237(NS), 80271(SA)
Emergency Medicine: 80102(NS), 80157(AS)
Endocrinology: 80238(NS), 80272(SA), 80103(AS)
Family Practice Including Obstetrics: 80421(SA), 80117(AS)
Family Practice-No Obstetrics (but formerly Obstetricians):
80486(NS), 80487(SA)
Family Practice-NO Obstetrics (FPs
formerly providing
Family Practice (No previous Obstetrics): 80420(NS),
80423(SA), 80117(AS)
Family Practice, No-OB, Major Invasive Procedures:
80422(NS), 80422(SA)
Family Practice, No-OB, Minor Invasive Procedures:
80443(NS), 80443(SA)
Forensic Medicine: 80240(NS)
Gastroenterology: 80241(NS),
80274(SA), 80104(AS)
Gastroenterology-Major Invasive:
80488(NS), 80488(SA)
General Preventive Medicine: 80231(NS)
Genetic Counseling: 80475(NS)
Geriatrics: 80243(NS), 80276(SA), 80105(AS)
Gynecology: 80244(NS), 80167(AS)
Gynecology-Former Obstetrics: 80483(NS), 80481(AS)
Gynecology, Former OB, still performing D&C under local:
80482(NS), 80481(AS)
Gynecology-Performing D&C under local: 80277(NS),
80167(AS)
Hematology: 80245(NS), 80278(SA)
Hypnosis: 80232(NS)
Infectious Diseases: 80246(NS), 80279(SA)
Intensive Care Medicine: 80283(NS)
Internal Medicine: 80257(NS), 80284(SA)
Internal Medicine-Major Invasive Procedures: 80489(NS),
80489(SA)
Laryngology: 80258(NS), 80285(SA),
80106(AS)
Legal Medicine: 80240(NS)
Neonatal: 80471(NS), 80474(AS)
Neoplastic Diseases: 80259(NS),
80286(SA), 80107(AS)
Nephrology: 80260(NS), 80287(SA), 80108(AS)
Neurology-Including Children: 80261(NS), 80288(SA), 80152(AS)
Nuclear Medicine: 80262(NS)
Nutrtion: 80248(NS)
Occupational Medicine: 80233(NS)
Oncology: 80473(NS)
Ophthalmology: 80263(NS), 80289(SA), 80114(AS)
Orthopedics-Including Closed Fractures: 80470(NS)
Orthopedics-No Surgery: 80469(NS)
Otology: 80264(NS), 80290(SA), 80158(AS)
Otorhinolaryngology: 80265(NS), 80291(SA),
80159(AS)
Pathology: 80266(NS), 80292(SA)
Pediatrics: 80267(NS), 80293(SA), 80474(AS)
Perinatology: 80168(AS)
Pharmacology: 80234(NS)
Physical Medicine and Rehabilitation: 80235(NS)
Psychiatry: 80235(NS)
Psychiatry-Including Children: 80249(NS)
Psychiatry-Including Shock Therapy: 80492(NS), 80492(SA)
Psychoanalysis: 80250(NS)
Psychosomatic Medicine: 80251(NS)
Public Health: 80236(NS)
Pulmonary Diseases: 80269(NS)
Radiology-No Invasive Procedures: 80253(NS)
Radiology-Major Invasive Procedures (Radiation Therapy
Procedures): 80491(NS), 80491(SA)
Radiology-Minor Invasive Procedures (Angiography,
ERCP, Needle Biopsy, Etc.): 80280(NS), 80280(SA)
Rheumatology: 80252(NS)
Rhinology: 80247(NS), 80270(SA),
80160(AS)
Surgery-Abdominal: 80166(AS)
Surgery-Cardiac: 80141(AS)
Surgery-Cardiovascular: 80150(AS
Surgery-Colon and Rectal: 80155(AS)
Surgery-General (FPs who perform
surgery): 80143(AS)
Surgery-Hand: 80169 (AS)
Surgery-Head and Neck: 80170(AS)
Surgery-Other: 80402(AS)
Surgery-Obstetrics: 80168(AS)
Surgery-Obstetrics/Gynecology: 80153(AS)
Surgery-Orthopedics excluding Spine: 80501(AS)
Surgery-Orthopedic Including Spine: 80154(AS)
Surgery-Plastics: 80156(AS)
Surgery-Plastics-Otorhinolaryngology:
80155(AS)
Surgery-Thoracic: 80144(AS)
Surgery-Traumatic: 80171(AS)
Surgery-Urological: 80145(AS)
Surgery-Vascular: 80146 (AS)
Urgent Care Physicians: 80424(NS)
By Weldon (Don)
Havins, M.D., J.D., CCMS Executive Director/CEO and Special Counsel
Insurance Update
Dr. Chanderraj's article details
information obtained from the Governor's "Nevada Essential Insurance
Association," also known as the "Medical Liability Association of
Nevada." The insurance premium
quotes are "proposed" premiums submitted to the Insurance
Commissioner by the Directors of the Medical Liability Association of
Nevada. The Insurance Commissioner has
not, at the time of writing this editorial, approved these premium rates. We are informed that the proposed rates,
which are substantially lower than those mentioned by the Governor earlier, are
subject to underwriting adjustments of up to 100%. Updates on the Governor's NEIA may be found
on the Division of Insurance's excellent website: http://www.doi.state.nv.us
A non-profit physician-owned mutual insurance company has
been approved by the Division of Insurance and granted a "Solicitation
Permit." The Nevada Mutual
Insurance Company reports that they are accepting applications and quoting
premiums at the level of the current St. Paul Company approved rates, with
discounts off those rates depending on claim history. Premiums are being quoted at the mature
claims-made levels, which include prior acts coverage. Prior acts coverage substitutes for
"tail coverage." These policies,
once issued, will eliminate the need to purchase tail coverage from a former
insurer. Of course, when the insured
leaves the new company, or the new company (for whatever reason) ceases writing
coverage for insureds, a tail coverage policy will
need to be purchased. Representatives of the Nevada Mutual Insurance Company
state they need to raise three million dollars before policies may be issued,
with a target date of May 1st to reach this goal. Allan Stipe, CEO
and Executive Director of Columbia Sunrise Hospitals, has committed financial
support to the Nevada Mutual Insurance Company.
Nevada Mutual Insurance Company representatives report they will seek
the financial support of other area hospitals.
For more information concerning the Nevada Mutual Insurance
Company contact Richard Bray or Chip Wallace by phone at (702) 699-5623; fax
(702) 796-5832.
Two other potential insurance companies have applications
pending in the Division of Insurance.
Antitrust Considerations
Complicating the agony of the medical malpractice insurance
availability and affordability crisis are progressively decreasing
reimbursements for medical services rendered.
Between now and 2005, Medicare reimbursements will decrease by 19%. This decrease is compounded by numerous managed
care companies tagging their health care provider contracts to the Medicare
schedule.
More than one physician group has inquired about the
legality of utilizing some type of collective action for leverage in contract
negotiations. Because physicians in
private practice are not employees, they cannot organize to collectively
bargain for reimbursements under the Taft-Hartley Act. According to the Sherman Act (15 USC § 1),
any contract, combination, or conspiracy in the restraint of trade is a violation
of federal law. So, the Sherman Act
prohibits any agreement or conspiracy that unreasonably restrains
competition. For an agreement to be
proven, the government must show that the parties must have been legally
capable for agreeing (or conspiring) and have actually agreed. Actions of a single legal entity cannot
violate the Sherman Act because one cannot agree or conspire with oneself. Business entities such as medical practices
wholly owned by more than one physician cannot be guilty of agreeing or
conspiring among the physicians of that entity.
However, among legally distinct parties, an agreement arises when the
parties had a unity of purpose or a common design and understanding, or a
meeting of the minds in an unlawful arrangement. Such an agreement can be inferred using
circumstantial evidence.
If an agreement induces a particular action, the action will
be subject to antitrust legal analysis to determine if the agreement
unreasonably restrains competition. The
analysis utilizes two standards to access the competitive effects: "per
se" analysis and "rule of reason" analysis. Per se analysis applies to agreements which
appear to have no procompetitive justification or
lack any redeeming competitive virtue.
These actions are "per se" illegal. Examples of such actions include group
boycotts, price fixing, rigging competitive bidding processes, and tying
arrangements where one product or service cannot be purchased unless another is
as well. No actual anticompetitive
effects of the agreement need be shown.
Rule of reason analysis requires the plaintiff or government
prosecutor to first establish the relevant market and the relevant geographic
area that effects competition. The
plaintiff must establish that the defendants had "market power" or
the ability to raise prices above the competitive level by restricting
competition. The judge or jury then
assesses the procompetitive and anticompetitive
effects of the action to determine if a violation of the Sherman Act occurred.
Lawsuits contending violations of the Sherman Act may be
brought by private parties (insurers), state attorneys general, the Federal
Trade Commission, and the Department of Justice. Both civil and criminal penalties are
available under the Sherman Act.
Criminal violations must result in corporate fines of up to $10,000,000
or twice the pecuniary loss of the victims, and individual fines of up to
$350,000, twice the pecuniary gain derived by the illegal activity, whichever
is greatest, and imprisonment of up to three years. These penalties have been, and continue to
be, applied against health care providers.
Private parties must demonstrate violation of the Sherman Act, an injury
to the plaintiff's business, and a causal relationship between the antitrust
violation and the injury. Damages are
three times actual damages plus attorney fees, and/or an injunction against the
defendants.
Section 2 of the Sherman Act prohibits monopolization and
attempted monopolization by an individual party with market power. Plaintiffs must demonstrate the relevant
product (or service) geographic market, that the defendant has or had monopoly
power and utilized that power, and the defendant's monopoly power was obtained
or extended by predatory or unreasonably anticompetitive conduct. Monopoly power is the ability to exclude
competition or to control price.
Monopoly power may be inferred if the defendant has more than 65% of the
market share and engaged in some activity to deter other potential competitors
from entering the market. The same
penalties apply to violations of Section 2 as do to Section 1 including the
right of private parties to bring a lawsuit.
The Clayton Act prohibits business consolidations if the
effect may be substantially to lessen competition, or tend to create a
monopoly. Mergers within the health care
field fall under this act. Criminal and
civil penalties are the same as for violation of the Sherman Act.
The Federal Trade Commission Act specifically prohibits
"unfair methods of competition."
The broad language provides the FTC with power to prosecute actions
outside the scope of the Sherman and Clayton Acts. Only the FTC and DOJ can prosecute actions under
this act.
Exclusive
Physician Network Joint Ventures
Physician network joint ventures have safety zones under
which physician networks will not be challenged by the FTC or DOJ. For instance, in an exclusive IPA joint
venture, the government will not prosecute when the physician participants
share substantial financial risk and constitute 20% or less of the physicians
in each physician specialty with active hospital staff privileges practicing in
the relevant geographic market. In an
exclusive joint venture, physician participants do not individually contract or
affiliate with other network joint venture or health plans. Where there are fewer than five physicians in
a particular specialty, and exclusive physicians network otherwise qualifying
for this antitrust safety zone may include one physician from that specialty on
a nonexclusive basis, even though this inclusion would result in the venture
having greater than 20% of the physicians in that specialty.
Non-Exclusive
Physician Network Joint Ventures
The FTC and DOJ will not challenge a non-exclusive physician
network whose physician-participants share substantial financial risk and
constitute 30% or less of the physicians in each physician specialty with
active hospital staff privileges who practice in the
relevant geographic market.
Participating physicians do or can affiliate with other networks or
contract individually with health plans.
In markets with fewer than four physicians in a particular specialty,
one may be a member of the joint venture.
The non-exclusivity must be true, not merely based on the contractual
agreement. Indicia of nonexclusivity are:
1.
Viable competing networks or managed care plans with adequate physician
participation existing in the market.
2.
Physicians in the network actually contract with other managed care
plans or other networks.
3.
Physicians in the network earn substantial revenue from individual
contracts with managed care plans or from other networks.
4.
The absence of evidence of coordination among network physicians
regarding price or terms of participation in other networks or managed care
plans.
Sharing Risk
The FTC and DOJ consider risk sharing to be a reliable
indicator of sufficient integration of the physician network providing
incentives for physicians to cooperate in controlling costs and improving
quality of medical care. Examples of
substantial risk sharing are:
1.
Agreement by the venture to provide capitated
services.
2.
Agreement to provide service to a health plan on a percentage of premium
or percentage of revenue basis.
3.
Use of financial incentives to achieve specified cost-containment goals
such that physicians are subject to financial rewards or penalties based on
group performance.
4.
Use of global fee or all-inclusive case rate arrangements.
Physician networks containing both
risk and non-risk sharing arrangements do not fall into the FTC and DOJ safety
zones. However, within the network,
different risk sharing arrangements are acceptable, such as capitation for
primary care physicians and specialty care provided on a reduced fee and
withhold basis.
Joint Ventures not falling within these
safety zone criteria will be analyzed using the rule of reason analysis
to determine if the network's procompetitive effects
are greater than the network's anticompetitive effect.
Messenger Model
(IPA) arrangements
Messenger model networks use an agent or third party to
convey to purchasers information obtained individually from providers about
prices or price-related information which providers are willing to accept. The messenger agent usually conveys to
providers all contract offers made by purchasers, with each provider making an
independent, unilateral decision to accept or reject the contract offer. In some cases the messenger agent may have
authority from individual providers to accept contract offers on their
behalf. The messenger agent may also
help providers understand the contracts offered by providing objective
information regarding the terms of an offer in comparison to other contracts
agreed to by network participants.
The messenger model arrangements must avoid facilitating an
agreement among competitors on prices or price-related terms, which would
thereby make the arrangement illegal.
The messenger agent must facilitate only independent, unilateral
decisions by participating network physicians.
A messenger agent who coordinated provider responses to a proposal,
expresses an opinion on the terms offered, collectively negotiates for the
providers, or determines whether or not to convey an offer based on the agent's
judgment about the attractiveness of the prices or price-related terms of the
offer engages in illegal price fixing which constitutes a per se violation of
the Sherman Act.
Two messenger model IPAs are
functioning in
An excellent seminar on the formation, operation, and
marketing of IPAs was presented by Kelly Testolin, Esq. of Hale, Lane,
If you have any pertinent information about the following
membership candidates, please contact:
Yvonne Barry, MD, Family Practice
Said T. Daneshmand, MD, Reproductive
Endocrinology & Infertility
Eric A. Gerson, MD, Radiology
Deborah A. Kuhls, MD, Trauma
Surgery
David T. Kuo, DO, Vascular/Diagnostic
Radiology
R. Garn Mabey, Jr., MD, Ob-Gyn
Congratulations and Welcome to the
Active Members
Cornell Clark, MD, Family Practice,
Tammy Kelly-Layton, MD, Ob-Gyn,
Gary Mayman, MD,
Pediatric Cardiology,
Active Limited Member
Kenneth Osgood, MD, Pediatrics,
Associate Member
Mona Sinno, MD, Family Practice, 4700 Las Vegas Blvd. North, Nellis AFB, NV 89191
By Weldon (Don)
Havins, M.D., Esq., CEO and Special Counsel,
The Nevada Medical Liability Physician Task Force has
declared its goal of seeking medical liability reform patterned after the MICRA
(Medical Injury Compensation Reform Act of 1975) law of
MICRA's main provisions affecting
medical malpractice actions against health care providers are as follows: a limitation on non-economic damages; the
admissibility of collateral source benefits; a shortened statute of
limitations; a sliding-scale limitation on attorney contingency fees; a
provision for periodic payment of future damages; a ninety-day notice of
intention to sue; and, a provision for binding arbitration agreements.
Juries frequently are asked to divide or apportion personal
injury awards into six categories: past medical damages; past lost wages; past
pain and suffering; future medical damages; future lost wages; and future pain
and suffering. Plaintiff attorneys ask
for this breakdown, in part, because awards for lost wages are taxable as
income whereas awards for medical damages and for pain and suffering are not
taxable as income. Without such
apportionment, the IRS is likely to contend a larger portion of the award was
for lost wages and demand income tax payment on that amount. In my experience observing personal injury
cases as a law clerk intern, the largest portion of jury awards were
apportioned for pain and suffering.
Limitation on
Non-economic Damages
Attorney
Contingency Fee Limits
The only significant amendment to MICRA since its inception
occurred in 1987 when the maximum attorney contingency fee contract limits were
increased. Now plaintiff attorneys may
recover 40% of the first $50,000 recovered, 33 and 1/3% of the next $50,000,
25% of the next $500,000, and 15% of an excess over $600,000. These limits apply whether the recovery is by
settlement, judgment, or arbitration.
Health care providers' conduct outside the scope of medical malpractice
does not limit the recovery percentage. There have recently been large awards
against physicians under the theories (reason for suing) of conspiracy and for
elder abuse, rather than for medical malpractice.
Elimination of
Joint and Several Liability
MICRA eliminated "Joint and Several" liability in
medical malpractice cases. Joint and
several liability is commonly known as "deep pocket" liability
wherein a defendant determined to be responsible for only a small portion of
the fault in the case may be required to pay the entire award. In
Periodic Payment
of Future Damages
MICRA provides that, upon request
by either party, the court must order periodic payment for future damages of
$50,000 or more. Future damages include
future medical damages (expenses), future lost wages, and future pain and
suffering. This provision of MICRA was
held constitutional by the California Supreme Court nine years after the adoption
of MICRA.
The
Collateral Source
Benefit Admissibility
Collateral source benefits are payments made to the
plaintiff by health insurance, disability insurance, accident insurance, or
workers compensation. MICRA law provides
that the health care provider defendant may introduce evidence of collateral
source benefits (except those from Medicare and other federally funded
collateral source benefits, and those from ERISA self-funded plans). If the defendant provides evidence of
collateral source benefits, the plaintiff may introduce evidence of the costs
of these benefits. When this occurs, the
providers of these benefits are precluded from recovering payments made to the
plaintiff (the insurance providers have no right of
"subrogation"). In effect,
this imposes some of the costs of medical malpractice onto the collateral
benefit providers rather than upon the negligent health care provider. The California Supreme Court held this
provision of MICRA constitutional in 1985, some ten years after its adoption by
the legislature.
In
Statute of
Limitations in Medical Malpractice Actions
MICRA law provides that the plaintiff must bring the cause
of action for medical malpractice within one year of the date of the injury or
one year from the time the plaintiff discovers, or should have reasonably
discovered, the injury, but in no event more than three years after the injury
unless there is fraud, intentional concealment, or the presence in the body of
a non-therapeutic foreign body. In 1982, the
Nevada law provides that the statute of limitation on
medical malpractice is two years from the date of injury or from the time the
plaintiff should have reasonably discovered the injury to a maximum of four
years excepting for brain injuries of children (ten years of age) and discovery
of sterility by the minor (eighteen years plus two, equals twenty years statute
of limitations).
Ninety-Day Notice
of Intention to Sue
MICRA provides that the plaintiff
shall give the health care provider at least a ninety-day notice of intention
to sue. If the notice is given within
ninety days of the statute of limitations, the statute of limitations is
extended to accommodate the ninety-day notice.
Failure to comply has no effect on the right to sue for medical
malpractice but does subject the attorney to a disciplinary action by the
Compulsory
Arbitration Agreements
MICRA authorizes compulsory
(binding) arbitration agreements in medical service contracts. The agreement must be in the first article of
the contract and must use specific language.
Immediately before the signature line other specific language must appear
in bold type of at least 10 point type.
Once signed, the agreement binds the parties to arbitrate disputes
regarding the provision of medical services unless the agreement is rescinded
within thirty days of signing. The
constitutionality of compulsive arbitration agreements has not been challenged primarily because
courts have recognized the strong public policy favoring arbitration as a means
of resolving disputes.
Summary
Reviewing the above, one could conclude that arbitration
contracts do not, at this point, significantly differ in
The ninety-day notice of intention to sue seems
insignificant. You know you are going to
be sued for medical malpractice thirty days before you are served the summons
and complaint. There is no joy in the
anticipation.
The statute of limitations provision may be slightly more
restrictive in
The main difference between the
The periodic payment of future damages in California
includes all future damages and any party may request periodic payments when
the award is over $50,000; in Nevada, only the claimant (successful plaintiff)
may request periodic payments and these may only be for future economic (future
lost wages and future medical expenses awarded) damages.
With Nevada physicians' incomes dropping due to decreasing
reimbursements, and overhead increasing due primarily to inordinate malpractice
premium raises, physicians may feel that limiting attorney contingency fees is
only fair. However, there is no credible
evidence from other States correlating limitation of attorney contingency fees
with medical malpractice insurance availability or affordability.
The one factor mentioned again and again by insurers at the
Nevada Insurance Commissioner's March 4th meeting was the imperative of
establishing a limitation on non-economic damages in
There are some in the plaintiff's bar who state that any
limitation on non-economic damages will destroy Nevadans' rights to their day
in court. There are physicians in
The medical malpractice plaintiffs' bar professes no
interest in discussing the possibility of any limitation on non-economic
damages. The plaintiffs' bar adamantly
declares there is no correlation between MPLI premium rates and States with and
without non-economic damages caps. This
may be true when "all" States are considered. However, many States have ridiculously high
limits on non-economic damage caps (such as
Cardiovascular
Consultants 691-9154
Southwest Medical
Associates 242-7347
Some courses also approved for nursing CEUs.
5/9 - “Latest Clinical Standards and Interventions:
Providing Optimal Diabetes Care,”
UMC 383-2604
5/18 - “Respiratory Symposia,” Palace Station Hotel &
Casino,
5/14 - “Hodgkins Disease: An
Overview,”
5/28 - “Venous Thromboembolic
Disorders,”
6/11 - “The Use of Intravenous PPI’s,”
6/25 - “Update on Asthma,”
7/9 - “Vaginal Births After
Cesarean Sections (V-Bacs),”
7/23 - “Making the Valley Hospital Web site Work For You and Your Patients,”
*Special Note: CCMS
members can receive free CME courses on the internet with World Medical
Leaders.
To have your CME courses listed on our calendar, please contact Deborah Barton at 739-9989 prior to the deadline of the 12th of each month.
MARCH
2002
DISEASE
|
CASES REPORTED |
YEAR TO DATE |
||
|
|
Mar. 2001 |
Mar. 2002 |
2001 |
2002 |
VACCINE
PREVENTABLE DISEASES
|
||||
|
DIPTHERIA |
0 |
0 |
0 |
0 |
|
HAEMOPHILUS
INFLUENZA (invasive) |
1 |
2 |
1 |
3 |
|
HEPATITIS A |
8 |
3 |
28 |
9 |
|
HEPATITIS B |
5 |
4 |
9 |
7 |
|
INFLUENZA |
4 |
27 |
28 |
51 |
|
MEASLES |
0 |
0 |
0 |
0 |
|
MUMPS |
||||